E.g., 10/14/2019
E.g., 10/14/2019
Title Category Credit Event Date Pricesort ascending
Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease & CRPC Webcast 013IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 There has been a dramatic increase in our understanding of the role of genetic testing in prostate cancer over the last several years. While the clinical impact of BRCA1/2 mutations has been well established in the setting of breast and ovarian cancer with critical implications for treatment (e.g.
Best of AUA: OAB: International Webinar (2017) $0.00 AUA is pleased to bring this 90 minute FREE non-cme webinar educational series to the global urologic community.  Dr. Robert J. Evans (Wake Forest) will be joined by expert faculties Drs. Howard B. Goldman (Cleveland Clinic) and Anurag Das (Beth Israel) for an exciting program featuring didactic lectures on the Urodynamic Evaluation and Advances in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction as well as Highlights and Take Home Messages from AUA 2016 for treating Female Urology, Incontinence, and Urodynamics. 
Update Series (2016) Lesson 30: Genetics in Urology: A Urologist’s Guide to the Genetic Revolution $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Complex Patient Cases in Bladder Cancer Webcast (2017)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.
Update Series (2019) Lesson 11: Biomarkers for Bladder Cancer Detection
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast 072IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will review the most recent AUA practice guidelines for non-muscle-invasive bladder cancer and detail strategies to manage common clinical predicaments involved in the management of these tumors. Specifically we will review: the AUA guidelines; risk stratification and use of cystectomy; selection of the optimal intravesical agent at the right schedule; and treatment of toxicity from intravesical therapy. Practical solutions will be presented that can be readily integrated into the office setting.
Advanced Practice Provider Core Curriculum: Hypogonadism (2017)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Member only benefit! Results of a recent survey sent to US based practicing urologists show that there has been an increase in the number of advanced practice providers (APPs) actively providing front-line urologic care. Based on these findings, it was determined that the AUA develop a modular curriculum to be used in advancing the standard of urologic education for APP’s. This educational curriculum, developed in partnership with the Cleveland Clinic, is comprised of online videos targeted towards the most common reasons patients seek non-operative urologic care.
Update Series (2019) Lesson 27: 2018 AUA Erectile Dysfunction Guidelines
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
Update Series (2019): Test Your Knowledge Lessons 21-25 $0.00 NEW – For our annual subscribers, we are excited to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:Allows you to answer 25 questions in random order as many times as you want.Provides feedback.Doesn’t require a passing score.It is only for our subscribers! 
Masterclass Webinar: Testosterone Deficiency (Espanol) (2018) $0.00 AUA is pleased to bring this FREE 60-minute, non-cme online educational series, presented in Spanish to the global urologic community.  Dr. Alejandro Rodriguez is joined by expert faculties Drs. Rafael Carrion, Adrian Momesso and Miguel Rivero for an exciting program featuring didactic lectures from AUA2018 Second Opinion Cases on Testosterone Defiency. Specific topics include:
Update Series (2015) Lesson 12: Female Urinary Incontinence: The Value and Challenges of Randomized Controlled Trials $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2019) Lesson 3: Constipation and Fecal Incontinence—What the Urologist Should Know
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Update Series (2015) Lesson 29: Contemporary Management of Advanced Prostate Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2016) Lesson 15: Image Guided Radiotherapy for Prostate Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Webcast 023IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, prostate, and testis cancers. Indications, outcomes, and toxicities will be discussed as well as clinical trial concepts. Survivorship issues will also be a focus of the session, which will include short, direct didactic lectures as well as a question and answer period. Standard of care chemotherapy regimens (eg MVAC for urothelial carcinoma) as well as newer immunotherapy options (eg checkpoint inhibition for renal cell carcinoma) will be included.

Pages